Your source for the latest medtech news from AdvaMed and our members.
AdvaMed, the Medtech Association, today released the following statement from President and CEO Scott Whitaker on the U.S. Senate’s confirmation of Robert F. Kennedy, Jr. to serve as Secretary of…
RefleXion Medical, a theranostic oncology company, today announced the scheduled installation of its RefleXion® X1 platform with SCINTIX® biology-guided radiotherapy at Beverly Hills Cancer Center (BHCC), the first freestanding cancer center (FSCC)…
On the Medtech POV podcast, AdvaMed President and CEO Scott Whitaker sat down with recently retired U.S. Rep. Brad Wenstrup of Ohio, discussing lessons learned from the COVID-19 pandemic, illogical budgetary scoring…
AdvaMed, the Medtech Association, today released the following statement from President and CEO Scott Whitaker following the imposition of tariffs on products from Canada, Mexico, and China:
If you have media inquiries, please contact:
Jim Jeffries, Senior Vice President, Public Affairs, 206-225-5226
Today, AdvaMed, the Medtech Association, released its “Patients First Agenda,” a series of state-level policies aimed at improving lives and patient outcomes through increasing access to medical technology, accurate diagnostic…
Inflammatix, a pioneering host response diagnostics company, today announced that the U.S. Food and Drug Administration (FDA) has granted marketing authorization for the TriVerity™ Test System (TriVerity), a first-in-class molecular test for…
On the Medtech POV podcast , AdvaMed President and CEO Scott Whitaker sat down with Jacob “Jake” Leach, Executive Vice President and Chief Operating Officer at Dexcom, to discuss the…
MedTechVets, a leading nonprofit organization dedicated to helping military veterans transition and find a career with purpose in the Medical Technology Industry through education, mentoring, and networking, is pleased to…
Brought to you by AdvaMed, Medtech POV with Scott Whitaker is a podcast that covers the intersection of medtech and policy from every perspective.
Francis Medical, Inc., a privately-held medical device company developing an innovative and proprietary water vapor ablation therapy for the treatment of prostate, kidney and bladder cancer, today announced the completion…